You can also use the apriori probability of a positiv, instead of a cost, which can be roughly deduced from existing litterature.

The strenght here is that you get rid of an arbitrary decision (p-value) and instead use quantities that can be measured and critiqued by a skeptical reviewer.

But, in my experience with small data, the impact of the size of the dataset dwarfed the impact of the cost/probability.